KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cvs Health (CVS) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Cvs Health (CVS) over the last 8 years, with Q4 2025 value amounting to $29.0 million.

  • Cvs Health's Non Operating Income rose 1600.0% to $29.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $112.0 million, marking a year-over-year increase of 1313.13%. This contributed to the annual value of $112.0 million for FY2025, which is 1313.13% up from last year.
  • Cvs Health's Non Operating Income amounted to $29.0 million in Q4 2025, which was up 1600.0% from $26.0 million recorded in Q3 2025.
  • In the past 5 years, Cvs Health's Non Operating Income ranged from a high of $50.0 million in Q1 2021 and a low of $22.0 million during Q1 2023
  • Over the past 5 years, Cvs Health's median Non Operating Income value was $28.5 million (recorded in 2025), while the average stood at $32.5 million.
  • As far as peak fluctuations go, Cvs Health's Non Operating Income plummeted by 4883.72% in 2023, and later skyrocketed by 2083.33% in 2025.
  • Quarter analysis of 5 years shows Cvs Health's Non Operating Income stood at $38.0 million in 2021, then increased by 13.16% to $43.0 million in 2022, then tumbled by 48.84% to $22.0 million in 2023, then rose by 13.64% to $25.0 million in 2024, then grew by 16.0% to $29.0 million in 2025.
  • Its Non Operating Income was $29.0 million in Q4 2025, compared to $26.0 million in Q3 2025 and $29.0 million in Q2 2025.